Isogenica

Isogenica is a drug discovery technology company focused on the design and build of state of the art fully synthetic, antibody libraries. These include single-domain VHH antibody libraries and fully synthetic human Fab antibody libraries. Our highly optimised and automated in vitro and phage display systems result in the rapid discovery of initial hits, isolating high-affinity binders that have therapeutic potential.

Organisation Type
Emma Sceats
CEO 
David Mead
Director Business Development